期刊文献+

新生儿持续肺动脉高压危险因素的Logistic回归分析 被引量:16

Logistic regression analysis of risk factors for persistent pulmonary hypertension of newborn infants
原文传递
导出
摘要 目的 探讨新生儿持续肺动脉高压(PPHN)发病的危险因素.方法 对41例PPHN新生儿进行1∶1配对病例对照研究,采用Х^2检验、t检验或方差分析等方法进行单因素分析,选择单因素分析中P值小于0.05的因素进行多因素Logistic回归分析,建立PPHN发病的Logistic回归预测模型,并对模型进行初步评价.结果 多因素Logistic回归分析显示胎粪吸入综合征(OR =52.391,95% CI:3.899~703.959)、孕母糖尿病(OR=49.758,95%CI:3.544~698.686)、新生儿肺炎(0R=49.637,95%CI:6.143 ~401.100)、宫内发育迟缓(OR=26.666,95%CI:2.997~237.282)、新生儿肺透明膜病(OR=15.200,95%CI:2.862~ 80.726)与PPHN发病明显相关.预测回归模型的拟合优度的Х^2检验结果为23.681,模型检验有统计学意义(P<0.01).结论 胎粪吸入综合征、孕母糖尿病、新生儿肺炎、宫内发育迟缓、新生儿肺透明膜病为PPHN发病的主要危险因素. Objective To explore the risk factors for persistent pulmonary hypertension of the newborns (PPHN).Methods An 1 ∶ 1 matched case-control study was conducted in 41 cases of PPHN.Chi-square,t-test or ANOVA were used to perform univariate analysis.All factors for P values less than 0.05 were used as independent variables for multivariate analysis of Logistic regression,and a predictive model of Logistic regression for the genesis of PPHN was established,and the model was evaluated preliminarily.Results By multivariate analysis of Logistic regression,meconium aspiration syndrome (OR =52.391,95 % CI:3.899-703.959),matemal diabetes (OR =49.758,95 % CI:3.544-698.686),neonatal pneumonia (OR =49.637,95% CI:6.143-401.100),intra-uterine growth restriction (OR =26.666,95% CI:2.997-237.282),hyaline membrane disease (OR =15.200,95 % CI 2.862-80.726) were significantly related to genesis of PPHN.Goodness of fit for predictive model of Logistic regression was checked by Chisquare and Х^2 value was 23.681.It indicated model check was statistically significant (P 〈 0.01).Conclusions Meconium aspiration syndrome,maternal diabetes,neonatal pneumonia,intra-uterine growth restriction,and hyaline membrane disease are major risk factors for genesis of PPHN.
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2013年第18期1405-1408,共4页 Chinese Journal of Applied Clinical Pediatrics
基金 郑州市科技攻关资助项目(20120845)
关键词 持续肺动脉高压 危险因素 LOGISTIC分析 婴儿 新生 Persistent pulmonary hypertension Risk factor Logistic analysis Infant, newborn
  • 相关文献

参考文献22

  • 1Teng R J,Wu TJ. Persistent pulmonary hypertension of the newborn[J].Journal of the Formosan Medical Association,2013,(04):177-184.
  • 2Steinhorn RH. Neonatal pulmonary hypertension[J].Pediatric Critical Care Medicine,2010,(Suppl 2):79-84.
  • 3金汉珍;黄德珉;官希吉.实用新生儿学[M]北京:人民卫生出版社,2003421-567.
  • 4Gao Y,Raj JU. Regulation of the pulmonary circulation in the fetus and newborn[J].Physiological Reviews,2010,(04):1291-1335.
  • 5余剑,冯星,孙斌.新生儿持续肺动脉高压临床与死亡相关因素分析[J].苏州大学学报(医学版),2011,31(1):169-171. 被引量:7
  • 6倪黎明.新生儿持续肺动脉高压[J].实用儿科临床杂志,2011,26(2):86-88. 被引量:25
  • 7Rocha G,Baptista M J,Guimaraes H. Persistent pulmonary hypertension of non cardiac cause in a neonatal intensive care unit[J].Pulm Med,2012.818971.
  • 8Storme L,Aubry E,Rakza T. Pathophysiology of persistent pulmonary hypertension of the newborn:impact of the perinatal environment[J].Archives of Cardiovascular Diseases,2013,(03):169-177.
  • 9Houeijeh A,Aubry E,Coridon H. Effects of n-3 polyunsaturated fatty acids in the fetal pulmonary circulation[J].Critical Care Medicine,2011,(06):1431-1438.
  • 10Dargaville PA,Copnell B,Mills JF. Randomized controlled trial of lung lavage with dilute surfactant for meconium aspiration syndrome[J].Journal of Pediatrics,2011,(03):383-389.e2.

二级参考文献24

  • 1杜军保,石云.新生儿持续肺动脉高压[J].中国新生儿科杂志,2006,21(3):181-184. 被引量:19
  • 2杜立中.新生儿持续肺动脉高压诊治的若干进展[J].临床儿科杂志,2006,24(11):869-872. 被引量:31
  • 3Walsh -Sukys MC, Tyson JE, Wright LL,et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide practice variations and outcomes[ J]. Pediatrics ,2000,105 ( 1 ) : 14 - 20.
  • 4Thebaud B, Petit T, de Lagausie P, et al. Altered guanylylcyclase activity in vitro of pulmonary arteries from fetal Iambs with congenital diaphrag-matic hernia[J]. Am J Respir Cell Mol Boil ,2002,27 ( 3 ) :42 - 47.
  • 5Kinsella JP, Tmug WE, Walsh WF, et al. Randomized, multieenter trial of inhaled nitric oxide and high frequency oscillation ventilation in severe, persistent pulmonary hypertension of the newbom[J]. J Pediatr, 1997,131 ( 1 ) :55 -62.
  • 6Baquero H, Soliz A, Neira F, et al. Oral sildenafil in infants with persis- tent pulmonary hypertension of the newborn: A pilot randomized blinded study[J]. Pediatrics,2006,117(4) : 1077 - 1083.
  • 7Ichiba H, Fujioka H, Saitoh M, et al. Neonatal listeriosis with severe respiratory failure responding to nitric oxide inhalation [ J ]. Pediatr Int, 2000,42(6) :696 -698.
  • 8Skimming JW, Bender KA, Hutchinson AA, et al. Nitric oxide inhalation in infants with respiratory distress syndrome [J]. J Peditar, 1997,130(2) :225 -230.
  • 9Diaz SH, Van Marter LJ, Werler MM, et al. Risk factors for persistent pulmonary hypertension of the newborn [ J ]. Pediatrics, 2007, 120 (2) : 272 - 282.
  • 10Christina DC, Diaz SH, Van Marter LJ, et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn [J]. N Engl J Med, 2006, 354(6): 579-587.

共引文献32

同被引文献133

  • 1孙眉月.新生儿呼吸衰竭治疗的新进展[J].中华急诊医学杂志,2004,13(6):368-369. 被引量:12
  • 2杜立中.新生儿持续肺动脉高压诊治的若干进展[J].临床儿科杂志,2006,24(11):869-872. 被引量:31
  • 3邵肖梅,叶鸿瑁,丘小汕.实用新生儿学.第4版.北京:人民卫生出版社,2011.
  • 4邵肖梅,叶鸿瑶,丘小汕.实用新生儿学[M].4版.北京:人民卫生出版社,2011:807-808.
  • 5Steinhorn R H.Neonatal pulmonary hypertension[J].Pediatr Crit Care Med, 2010, 11(2Suppl): $79-$84.
  • 6Razzaq A, lqbal Quddusi A, Nizami N.Risk factors and mortality among newborns with persistent pulmonary hypertension[J].Pak J Med Sci, 2013, 29(5): 1099-1104.
  • 7Nair J, Lakshminrusimha S.Update on PPHN: Mechanisms and treatment[J].SeminPerinatol, 2014, 38(2): 78-91.
  • 8Catteruccia M, Verrigni D, Martinelli D, et al.Persistent pulmonary arterial hypertension in the newborn(PPHN): A frequent manifestation of TMEM70 defective patients[J].Mol Genet Metab, 2014, 111(3): 353-359.
  • 9Latini G, Del Vecchio A, De Felice C, et al.Persistent pulmonary hypertension of the newborn: therapeutical approach[J].Mini Rev Med Chem, 2008, 8(14): 1507-1513.
  • 10Teixeira-MendongaC, Henriques-Coelho T.Pathophysiology of pulmonary hypertension in newborns: therapeutic indications[J].Rev Port Cardiol, 2013, 32(12): 1005-1012.

引证文献16

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部